Q4142 identifies XCM biologic tissue matrix; Q4143 identifies Repriza. Choose according to the product documented as applied.
On this page
CMS RVU26D · Effective 2026-10-01
Q4143 Wound tissue product Medicare reimbursement rates in Virginia
Q4143 identifies Repriza wound tissue product reported by area when the product is applied during a separately coded wound-treatment procedure. Compare Q4143 office and facility rates across CMS payment localities in Virginia.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4143 in Virginia?
Virginia has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
$125.09–$149.91
2 of 2 localities have a supported rate.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care supplies
About Q4143: Repriza wound tissue product
Q4143 identifies Repriza wound tissue product reported by area when the product is applied during a separately coded wound-treatment procedure.
Q4143 identifies Repriza, a tissue product used in wound care. Wound-care clinicians and surgeons may apply it to a wound as part of treatment; the product code represents the material rather than the clinician’s evaluation or the wound-application work. The primary procedure code describes the application service, with the appropriate procedure selected for the wound site and treated area.
Report Q4143 with the required primary procedure, using units that match the amount of product applied and the code’s area-based measure. Documentation should identify Repriza, the wound treated, the area covered, and the quantity used; product records can support the material reported. CMS treats Q4143 as an add-on paid within the primary procedure’s global period, so it is not reported alone. CMS classifies it as technical-component-only, with interpretation covered by a separate code. Its CMS valuation has no physician work component and includes practice expense.
CMS billing rules for Q4143
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4143 compared with similar codes
Office rates for Virginia, from the same CMS release.
Q4146 identifies Tensix, while Q4143 identifies Repriza. The product name on the application and product record determines the code.
Amnio or biodmatrix, inj 1cc
Q4139 is for an injectable amnion or bio-matrix product measured by volume; Q4143 identifies Repriza and uses an area-based measure.
Epifix, inj, 1mg
Q4145 identifies injectable EpiFix measured by milligrams. Q4143 is the Repriza product code with an area-based measure.
Compare Q4143 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Dc + Md/Va Suburbs →
Office / nonfacility
$149.91
Facility
Unavailable
Virginia →
Office / nonfacility
$125.09
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Q4143 billing questions
When should Q4143 be selected instead of another wound-product code?
Use Q4143 when the product applied is Repriza. Similar wound products have their own HCPCS codes, so select by the product actually used rather than by wound type alone.
Can Q4143 be billed by itself?
No. CMS identifies it as an add-on that must be billed with a primary procedure and is paid within that procedure’s global period.
What documentation supports the units?
Record the product name, wound site, treated area, and amount of Repriza applied. Report units according to the code’s area-based measure and the quantity documented.
Does Q4143 include the wound-application service?
Q4143 represents the Repriza product. Report the applicable wound-application procedure separately as the primary procedure.
How does the component rule affect reporting?
CMS classifies Q4143 as technical-component-only. A separate code covers interpretation.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
